Lin Shao-Lee has filed 5 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 327537 shares of Cue Biopharma, Inc. ($CUE) on May 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 3, 2026 | Cue Biopharma, Inc. | $CUE | Lin Shao-Lee | CHIEF EXECUTIVE OFFICER | A | Common Stock | 327537 | $0.00 | 327,537.0000 | 100,869,349 | 9999.99% | 0.32% |
| May 3, 2026 | Cue Biopharma, Inc. | $CUE | Lin Shao-Lee | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 655074 | $0.00 | 655,074.0000 | 100,869,349 | 9999.99% | 0.65% |
| May 14, 2025 | Surrozen, Inc./DE | $SRZN | Lin Shao-Lee | Not found | A | Option (right to buy) | 1333 | $0.00 | 1,333.0000 | 3,281,169 | 9999.99% | 0.04% |
| June 5, 2024 | Surrozen, Inc./DE | $SRZN | Lin Shao-Lee | Not found | A | Option (right to buy) | 1333 | $0.00 | 1,333.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | Surrozen, Inc./DE | $SRZN | Lin Shao-Lee | Not found | A | Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |